1
|
Galí A, Ascaso M, Nardi-Ricart A, Suñé-Pou M, Pérez-Lozano P, Suñé-Negre JM, García-Montoya E. Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation. Pharmaceutics 2020; 12:pharmaceutics12080743. [PMID: 32784621 PMCID: PMC7465942 DOI: 10.3390/pharmaceutics12080743] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2020] [Revised: 08/04/2020] [Accepted: 08/05/2020] [Indexed: 11/16/2022] Open
Abstract
The objective of these studies is to verify and validate the improvement in the inter-tablet coating uniformity for an industrially commercialized coated tablet, without involving changes in the approved registration dossier. Using the CPP (critical process parameters) determined from previous retrospective statistical analysis, the recommended working ranges are identified. Retrospective analysis showed that the design of experiments (DoE) provided an improved process variable configuration. Therefore, it is decided to study two critical parameters: Product temperature and drum speed, with an additional 22 experimental design. The quality results of the samples analyzed show that the aesthetic defects of the batches made with the new working ranges have been reduced. These results have also been corroborated with the 42 industrial batches manufactured with the new ranges. With the optimized parameters, tablets have been coated and the suitability of the model determined. The results demonstrated the overall reliability and effectiveness of the proposed Quality by Design approach and provides a useful tool to help optimize the industrial coating process. This study confirms that it is possible to optimize and validate the manufacturing process of an existing commercial product by means of a DoE with retrospective data. Therefore, no variation in the dossier is required.
Collapse
Affiliation(s)
- Albert Galí
- PhD collaborator at the Pharmacy and Pharmaceutical Technology and Physical Chemistry Department, University of Barcelona, 08028 Barcelona, Spain; (A.G.); (M.A.)
| | - Magda Ascaso
- PhD collaborator at the Pharmacy and Pharmaceutical Technology and Physical Chemistry Department, University of Barcelona, 08028 Barcelona, Spain; (A.G.); (M.A.)
| | - Anna Nardi-Ricart
- Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27–31, 08028 Barcelona, Spain; (M.S.-P.); (P.P.-L.); (J.M.S.-N.); (E.G.-M.)
- Correspondence: ; Tel.: +34-93-402-45-46
| | - Marc Suñé-Pou
- Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27–31, 08028 Barcelona, Spain; (M.S.-P.); (P.P.-L.); (J.M.S.-N.); (E.G.-M.)
- Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group Bellvitge Biomedical Research Institute (IDIBELL), Av. Granvia de l’Hospitalet, 199–203, 08090 L’Hospitalet de Llobregat, Spain
| | - Pilar Pérez-Lozano
- Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27–31, 08028 Barcelona, Spain; (M.S.-P.); (P.P.-L.); (J.M.S.-N.); (E.G.-M.)
- Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group Bellvitge Biomedical Research Institute (IDIBELL), Av. Granvia de l’Hospitalet, 199–203, 08090 L’Hospitalet de Llobregat, Spain
| | - Josep M. Suñé-Negre
- Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27–31, 08028 Barcelona, Spain; (M.S.-P.); (P.P.-L.); (J.M.S.-N.); (E.G.-M.)
- Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group Bellvitge Biomedical Research Institute (IDIBELL), Av. Granvia de l’Hospitalet, 199–203, 08090 L’Hospitalet de Llobregat, Spain
| | - Encarna García-Montoya
- Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27–31, 08028 Barcelona, Spain; (M.S.-P.); (P.P.-L.); (J.M.S.-N.); (E.G.-M.)
- Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group Bellvitge Biomedical Research Institute (IDIBELL), Av. Granvia de l’Hospitalet, 199–203, 08090 L’Hospitalet de Llobregat, Spain
| |
Collapse
|
2
|
Galí A, García-Montoya E, Ascaso M, Pérez-Lozano P, Ticó JR, Miñarro M, Suñé-Negre JM. Improving tablet coating robustness by selecting critical process parameters from retrospective data. Pharm Dev Technol 2015; 21:688-97. [PMID: 26017851 DOI: 10.3109/10837450.2015.1045619] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
CONTEXT Although tablet coating processes are widely used in the pharmaceutical industry, they often lack adequate robustness. Up-scaling can be challenging as minor changes in parameters can lead to varying quality results. OBJECTIVE To select critical process parameters (CPP) using retrospective data of a commercial product and to establish a design of experiments (DoE) that would improve the robustness of the coating process. MATERIALS AND METHODS A retrospective analysis of data from 36 commercial batches. Batches were selected based on the quality results generated during batch release, some of which revealed quality deviations concerning the appearance of the coated tablets. The product is already marketed and belongs to the portfolio of a multinational pharmaceutical company. RESULTS The Statgraphics 5.1 software was used for data processing to determine critical process parameters in order to propose new working ranges. DISCUSSION AND CONCLUSIONS This study confirms that it is possible to determine the critical process parameters and create design spaces based on retrospective data of commercial batches. This type of analysis is thus converted into a tool to optimize the robustness of existing processes. Our results show that a design space can be established with minimum investment in experiments, since current commercial batch data are processed statistically.
Collapse
Affiliation(s)
- A Galí
- a Department of Pharmacy and Pharmaceutical Technology , University of Barcelona , Barcelona , Spain and.,b Department of Pharmaceutical Technology, Faculty of Pharmacy , University of Barcelona , Barcelona , Spain
| | - E García-Montoya
- b Department of Pharmaceutical Technology, Faculty of Pharmacy , University of Barcelona , Barcelona , Spain
| | - M Ascaso
- a Department of Pharmacy and Pharmaceutical Technology , University of Barcelona , Barcelona , Spain and
| | - P Pérez-Lozano
- b Department of Pharmaceutical Technology, Faculty of Pharmacy , University of Barcelona , Barcelona , Spain
| | - J R Ticó
- b Department of Pharmaceutical Technology, Faculty of Pharmacy , University of Barcelona , Barcelona , Spain
| | - M Miñarro
- b Department of Pharmaceutical Technology, Faculty of Pharmacy , University of Barcelona , Barcelona , Spain
| | - J M Suñé-Negre
- b Department of Pharmaceutical Technology, Faculty of Pharmacy , University of Barcelona , Barcelona , Spain
| |
Collapse
|